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Recent studies have demonstrated that embryonic stem cells
(ESCs) are deficient in expressing type I interferons (IFN), the
cytokines that play key roles in antiviral responses. However,
the underlying molecular mechanisms and biological implica-
tions of this finding are poorly understood. In this study, we
developed a synthetic RNA-based assay that can simulta-
neously assess multiple forms of antiviral responses. Dicer is an
enzyme essential for RNA interference (RNAi), which is used as
a major antiviral mechanism in invertebrates. RNAi activity is
detected in wild-type ESCs but is abolished in Dicer knockout
ESCs (D−/−ESCs) as expected. Surprisingly, D−/−ESCs have
gained the ability to express IFN, which is otherwise deficient
in wild-type ESCs. Furthermore, D−/−ESCs have constitutively
active double-stranded RNA (dsRNA)-activated protein kinase
(PKR), an enzyme that is also involved in antiviral response.
D−/−ESCs show increased sensitivity to the cytotoxicity
resulting from RNA transfection. The effects of dsRNA can be
partly replicated with a synthetic B2RNA corresponding to the
retrotransposon B2 short interspersed nuclear element. B2RNA
has secondary structure features of dsRNA and accumulates in
D−/−ESCs, suggesting that B2RNA could be a cellular RNA
that activates PKR and contributes to the decreased cell pro-
liferation and viability of D−/−ESCs. Treatment of D−/−ESCs
with a PKR inhibitor and IFNβ-neutralizing antibodies
increased cell proliferation rate and cell viability. Based on
these findings, we propose that, in ESCs, Dicer acts as a
repressor of antiviral responses and plays a key role in the
maintenance of proliferation, viability, and pluripotency of
ESCs.
The innate immune system is the first line of an organism’s
defense against a broad range of pathogen invasions. Although
innate immunity consists of different mechanisms, the anti-
viral response is one of the most critical components and is
presumably developed in most, if not all, mammalian cells
(1, 2). However, a series of our recent studies have demon-
strated that mouse embryonic stem cells (ESCs) have an
attenuated innate immune response. In particular, they do not
express type I interferons (IFN) and lack response to inflam-
matory cytokines. Similar observations have been made in
human ESCs and induced PSCs (iPSCs) (3, 4). Therefore, this
is a common property shared by all types of PSCs. It appears
that ESCs in the early embryo are immunologically divergent
from the traditional view of “innate immunity” established in
somatic cells of developed organisms.
The biological implications of the attenuated innate im-
mune responses in ESCs have been speculated from different
perspectives. Immune response is a double-edged sword: it
serves as a critical part of the defense mechanism, but it can
also cause immunologic toxicity to tissues since IFN and in-
flammatory cytokines negatively impact cell proliferation and
viability (5–7). While this could be tolerated by tissues of
developed organisms, it could cause serious damage to ESCs in
an early embryo. From this perspective, an attenuated immu-
nological response could serve as a self-protective mechanism
in ESCs by minimizing immunological cytotoxicity at early
stages of embryogenesis (8). From the perspective of ESC
biology, IFN response does not appear to be compatible with
the pluripotency of ESCs, as demonstrated by a recent study
showing that forced activation of the IFN pathway can cause
dysregulation of many pluripotency- and lineage-specific genes
in ESCs (9). Both scenarios are supported by strong experi-
mental evidence and are not mutually exclusive. However, they
only make biological sense if the deficiency in IFN production
does not compromise the defense capacity of ESCs. Indeed,
two alternative antiviral mechanisms have been proposed;
ESCs may use a subset of preexisting IFN-stimulated genes
(ISGs) that are independent of IFN stimulation (10), or they
may use the RNA interference (RNAi) antiviral pathway that
may not be operational in differentiated mammalian cells (11).
Although RNAi is widely recognized as a major antiviral
mechanism in invertebrates, such a function has not been
convincingly demonstrated in mammals. Interestingly, RNAi
activity was detected in viral infected mouse ESCs, pointing to
the possibility that RNAi could be an alternative antiviral
mechanism in ESCs, in which the IFN system is deficient (12).
However, the physiological significance of RNAi as an antiviral
mechanism in ESCs remains uncertain (13). Since Dicer is the
key enzyme responsible for miRNA and siRNA biogenesis,
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D−/−ESCs could be used as a loss-of-function model to
investigate the function of RNAi since they have retained the
basic morphology of ESCs and the capacity to express plu-
ripotency markers even though they display severe differenti-
ation and growth defects (14, 15). Interestingly, it was recently
reported that D−/−ESCs were able to express IFNβ and show
increased antiviral activity (16). Quite unexpectedly, our
studies using ESCs as a model to express proteins from syn-
thetic mRNA have led to new insights into the role of Dicer in
the regulation of antiviral responses in these cells. Direct
expression of a protein from its synthetic mRNA is an alter-
native to plasmid DNA- or viral vector-based gene expression
systems (17). A major biological issue with this method is that
synthetic mRNA transfected to the host cells is detected as
foreign RNA and elicits antiviral responses, leading to reduced
cell viability and apoptosis of the host cells (17). However, this
is not a serious problem in ESCs due to their attenuated
antiviral responses as we demonstrated in a recent study (18).
Taking advantage of this feature in ESCs, we attempted to use
green fluorescent protein (GFP) expressed from its synthetic
mRNA as a virus-free in vitro assay to determine RNAi activity
in this study. RNAi activity was indeed detected in wild-type
ESCs, but not in D−/−ESCs, as expected. However,
D−/−ESCs showed increased antiviral responses to RNA
transfection.
Viral RNA induces IFN response by interacting with toll-
like receptors (TLRs) and retinoic acid–inducible gene I
(RIG-I)-like receptors (RLRs), leading to IFN transcription
through activation of NFκB and IRFs (19–21). In addition, viral
RNA can also activate other antiviral mechanisms, such as
dsRNA-activated protein kinase R (PKR). Activation of PKR
causes inhibition of both cellular and viral protein synthesis.
While this represses viral replication, it also inhibits cell pro-
liferation (22). PKR is constitutively expressed in cells and is
readily activated by viral dsRNA or by dysregulated cellular
RNA, but it can be further upregulated by IFN as a part of the
IFN response. Thus, the IFN system can activate multiple
pathways and mount a powerful antiviral response (7).
While it is apparent that the deficiency of ESCs in
expressing IFN is closely related to pluripotency, the under-
lying molecular basis of this deficiency is poorly understood. In
this study, we demonstrate that D−/−ESCs have gained the
ability to express not only the type I IFN system, but also
constitutively active PKR, which together contribute to the
reduced cell proliferation and cell viability of D−/−ESCs. Our
data revealed a critical role of Dicer as a repressor of antiviral
responses in ESCs, which represents a novel mechanism
essential for ESCs to maintain rapid proliferation and to pre-
vent potential cell damage resulting from dysregulated
endogenous RNA transcripts.
Results
Development of an RNA-based assay to determine different
antiviral responses in ESCs
This assay was initially intended to determine the RNAi
activity in ESCs. Functionalized GFP-mRNA was first
transfected into cells where it was translated to GFP. The cells
were then transfected with a synthetic dsRNA corresponding
to the sequence of GFP (designated as dsGFP). Based on the
principle of RNAi, dsGFP would be processed to yield siRNA
that will specifically target GFP-mRNA, thereby reducing GFP
expression. GFP was detected as early as 3 h after GFP-mRNA
transfection. Subsequent transfection with either dsGFP or
dsLuc (a control luciferase dsRNA of similar length with a
sequence unrelated to GFP-mRNA) reduced GFP expression
as indicated by diminished green fluorescence (Fig.S1A).
Quantitative analysis by flow cytometry indicated that GFP
fluorescence intensity in ESCs was reduced more by dsGFP
than by dsLuc (Fig.S1B, 59% versus 76% at 24 h, in comparison
with control, 100%). However, in D−/−ESCs, both dsGFP and
dsLuc reduced the expression of GFP to a similar level (45%
versus 47%, at 24 h). A logical explanation for these results
would be that the different effect between dsGFP and dsLuc in
ESCs is due to sequence-specific reduction of GFP-mRNA by
dsGFP via Dicer-dependent RNAi activity, which is abolished
in D−/−ESCs. The non-sequence-specific effects in the
reduction of GFP fluorescence caused by dsGFP and dsLuc in
both ESCs and D−/−ESCs are likely due to the activation of
other pathways.
These results demonstrated the existence of RNAi ac-
tivity in ESCs, which is in agreement with the study using
GFP expressed from plasmids as an siRNA target (23).
However, the most notable observation is that transfection
of D−/−ESCs with dsRNA, and to a lesser extent with
GFP-mRNA, caused cell death, as judged by the increased
number of detached cells (Fig.S1A, D−/−ESC1), whereas
the cytotoxicity caused by dsRNA transfection in ESCs is
low and limited to reduced colony size (Fig.S1A, ESC1).
These results suggested that D−/−ESCs have increased
susceptibility to the cytotoxicity of transfected RNA. The
GFP-mRNA contains some uncapped GFP-mRNA, which
has a 5’ppp-group that can activate RIG-I (24). Therefore,
the RNA preparations used in the above experiments can
potentially interact with most, if not all, known RNA re-
ceptors, including TLR3, RIG-I, MDA5, and PKR, that can
potentially activate most of the common antiviral path-
ways. Therefore, cellular effects of RNA transfection on
ESCs and D−/−ESCs represent the collective results of
their antiviral responses. The increased antiviral response
in D−/−ESCs is a novel finding that we investigated
further with two independent pairs of ESC lines
(ESC1;D−/−ESC1 and ESC2;D−/−ESC2) in this study.
D−/−ESCs have increased capacity to express type I IFN
To determine the effect of Dicer deletion on the IFN
pathway, we transfected the cells with dsGFP or dsLuc and
analyzed the expression of IFNβ and ISG15 as indicators of the
functionality of the type I IFN system. As shown in Figure 1A,
the mRNA levels of the two genes were not or only slightly
increased in ESCs, but they were strongly stimulated in
D−/−ESCs. Similar results were observed when cells were
transfected with polyIC (polyinosinic-polycytidylic acid), a
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synthetic dsRNA used as a viral RNA analog in our previous
studies (25, 26) (data not shown).
It is known that certain cellular RNA with dsRNA structures,
including those from apoptotic cells, misprocessed RNA, and
transcripts of transposable elements (TEs), can induce antiviral
responses and cause cellular damage in the absence of infection
(27–29). The B2 short interspersed nuclear element (SINE) is a
major type of retrotransposons in mouse genomes (30).
Figure 1. dsRNA- and B2RNA-induced expression of IFNβ and ISG15 in ESCs and D−/−ESCs. ESCs and D−/−ESCs were transfected with dsRNA or B2RNA
for the indicated time periods. The mRNA levels of the tested genes were determined by RT-qPCR. A, dsGFP- and dsLuc-induced IFNβ and ISG15 mRNA. B,
B2RNA-induced IFNβ and ISG15 mRNA. C, relative cellular levels of B2RNA in ESCs and D−/−ESCs. D, Comparison of the basal mRNA levels of dsRNA re-
ceptors in ESCs and D−/−ESCs. For A and B, the mRNA level of each tested gene in the control ESCs (Con) is designated as 1. For C and D, the basal mRNA
level of each tested gene in ESCs is designated as 1. The values are as mean ± SD of three independent experiments (A and D) or a representative
experiment performed in biological triplicate that was performed at least twice (B and C). p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05.* Compared
groups are indicated by a horizontal bar.
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B2RNA, which has several features of dsRNA (31), is abun-
dantly expressed in mouse ESCs. As shown in Figure 1B, syn-
thetic B2RNA (B2) showed patterns similar to dsGFP and
dsLuc in inducing IFNβ and ISG15 expression in ESCs
and D−/−ESCs. It is noted that the endogenous B2RNA level in
D−/−ESCs was significantly higher than in ESCs, indicating its
accumulation in D−/−ESCs (Fig. 1C). If Dicer is responsible for
processing endogenous B2RNA, it could target the transfected
B2 RNA as well. To test this possibility, we transfected ESCs
and D−/−ESCs with Cy3-labeled fluorescent B2RNA (Cy3-B2)
and analyzed the levels of Cy3-B2 by Cy3 fluorescence intensity.
Our results indicated that Cy3-B2 was detected at higher levels
in D−/−ESCs than in ESCs (Fig. S2), consistent with the
accumulation of endogenous B2RNA in D−/−ESCs (Fig. 1C).
We also compared the basal mRNA levels of the RNA receptors
that mediate the effects of viral RNA. With the exception of
MDA5, which is expressed at higher levels in D−/−ESCs than in
ESCs, the other tested dsRNA receptors are expressed at
comparable levels (Fig. 1D).
D−/−ESCs have a functional type I IFN system
ESCs are able to respond to IFNα and IFNβ, but they are
unable to express the two cytokines (25, 26). To test if Dicer
deletion affects the responsiveness of ESCs to IFN, we treated
the cells with IFNα and compared IFNα-induced expression of
three ISGs (PKR, ISG15, and STAT1) in ESCs and D−/−ESCs.
IFNα induced expression of all three genes, with ISG15 mRNA
induced significantly higher in D−/−ESCs than in ESCs
(Fig. 2A). It is also noted that the basal mRNA levels of all
three ISGs are about threefold higher in D−/−ESCs than in
ESCs. At the protein level, STAT1 was detected in unstimu-
lated cells, but it was induced by IFNα in both ESCs and
D−/−ESCs. IFNα-induced PKR was also apparent in ESCs and
D−/−ESCs (Fig. 2B, left panel).
For a functional analysis of the IFN system, we prepared
conditioned medium (CM) from dsGFP-transfected ESCs and
D−/−ESCs (dsGFP[CM]). The rationale is that if the CM
contains IFN, it will induce ISGs, such as STAT1, resembling
the effects of IFNα (Fig. 2B). In this experiment, we used ESC-
differentiated fibroblasts (ESC-FBs) since they are much more
responsive to IFN than ESCs (32). As shown in Figure 2C,
dsGFP[CM] prepared from D−/−ESCs, but not that from ESCs
(blot inset), induced the expression of STAT1 in ESC-FBs.
This result indicated that dsGFP[CM] only from D−/−ESCs
contains secreted IFN, as confirmed by ELISA analysis of IFNβ
in the CMs (Fig. 2C, bar graph). Together, these data
demonstrate that D−/−ESCs have a fully functional type I IFN
system.
We further analyzed the expression levels of the major
signaling molecules that mediate the effects of IFN. As shown
in Figure 2D, RT-qPCR analysis indicated that most of these
molecules were expressed at comparable mRNA levels in ESCs
and D−/−ESCs although some variations were noted for JAK1,
IFNAR2, and STAT1 between the two different D−/−ESC
lines.
Figure 2. IFN responses in ESCs and D−/−ESCs. A, RT-qPCR analysis of
IFNα (500 units/ml)-induced PKR, ISG15, and STAT1 expression. The
mRNA level of each tested gene in the control ESCs (Con) is designated
as 1. B, western blot analysis of IFNα-induced expression of STAT1 and
PKR. C, blot inset, conditioned medium (CM)-induced expression of
STAT1. ESC-FBs were treated for 24 h with Con[CM] (prepared from ESCs
and D−/−ESCs without dsGFP transfection) and dsGFP[CM] (prepared
from ESCs and D−/−ESCs transfected with dsGFP). Con, cells without any
treatment. Bar graph, ELISA analysis of IFNβ in the medium secreted by
ESCs and D−/−ESCs in response to dsGFP. D, RT-qPCR analysis of the
basal mRNA levels of signaling molecules that mediate the effects of
type I IFN in ESCs and D−/−ESCs. The basal mRNA level of each tested
gene in ESCs is designated as 1. In bar graphs, the values are as mean ±
SD of three independent experiments (C and D) or a representative
experiment performed in biological triplicate that was performed at
least twice (A). p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05.*
Compared groups are indicated by a horizontal bar. In Western blot
analysis, the blots are representatives from experiments that were
repeated three times. β-Actin was used as a reference for protein
loading.
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The PKR pathway is constitutively active in D−/−ESCs
The PKR pathway is functional in ESCs as we demonstrated
with polyIC transfection and viral infection (25). To determine
if this pathway is also altered in D−/−ESCs, we treated the cells
with dsGFP or B2RNA. Although dsRNA is the best charac-
terized activator of PKR, single-stranded RNA having hairpin
structures with a certain length can also activate PKR (27–29).
Therefore, we speculated that B2RNA may be able to activate
PKR since it has a secondary structure with five hairpins, two
loops, and two single-stranded regions (31). PKR activation is
commonly assessed by the phosphorylation of eukaryotic
initiation factor 2α (peIF2α), which is a well-characterized PKR
substrate (6), and by the level of phosphorylated PKR (pPKR),
which is the active form of PKR. As shown in Figure 3, peIF2α
was detected in both ESCs and D−/−ESCs treated with dsGFP
and B2RNA, but levels of pPKR were much higher in
D−/−ESCs than in ESCs. However, the most notable obser-
vation is that both pPKR and peIF2α were detected in un-
treated D−/−ESCs but barely detected in untreated ESCs
(Fig. 3 Con), indicating that PKR is constitutively active in
D−/−ESCs.
D−/−ESCs have reduced cell proliferation rate and express
high levels of cell cycle inhibitors
ESCs are characterized by their rapid cell proliferation rate
due to constitutively activated cyclin-dependent kinases
(CDKs) driven by high expression levels of cyclins A, B, and E
(33). D−/−ESCs have a substantially lower growth rate than
ESCs (Fig. 4A). RT-qPCR analysis indicated that the mRNA
level of cyclin E and cyclin B appeared to be lower in
D−/−ESCs than in ESCs while cyclin A was not significantly
altered. However, three major cell cycle inhibitors, p21, p19,
and p16, which are expressed at very low levels in ESCs, are
expressed at substantially higher levels in D−/−ESCs (Fig. 4B).
These results explain, at least partially, the reduced cell pro-
liferation in D−/−ESCs.
Contribution of PKR activation to the reduced cell
proliferation in D−/−ESCs
PKR activation is known to inhibit cell proliferation,
including in ESCs as we previously demonstrated with polyIC-
activated PKR (25). To test if constitutively activated PKR in
D−/−ESCs contributed to their reduced cell proliferation, we
treated ESCs and D−/−ESCs with an imidazolo-oxindole PKR
inhibitor (C16), which shows a similar effect to siRNA that
knocks down PKR (25). As shown in Figure 5A, C16 treatment
significantly increased the cell number of D−/−ESCs in a dose-
dependent manner with the maximal effect at the concentra-
tion of 0.75 μM, but this dose dependence was not seen in
ESCs. We further analyzed the cells by flow cytometry. ESCs
have large populations at the S phase and similar cell pop-
ulations at the G1 and G2 phases when they are grown at low
density. However, in comparison, D−/−ESCs have increased
G1 cell populations and reduced S phase cell populations,
which are indicators of slowed cell cycle progression. Treat-
ment of D−/−ESCs with C16 reduced the G1 cell population.
At 0.75 μM and 1 μM, C16-treated D−/−ESCs have a cell cycle
profile with a ratio of G1 and G2 cells similar to ESCs.
Although the S phase cell population in ESCs was slightly
reduced by C16, the overall cell cycle profiles were not altered
(Fig. 5B), consistent with the unchanged cell proliferation rate
(Fig. 5A). The effect of C16 on the inhibition of PKR was
confirmed by knocking down PKR expression with its specific
siRNA, leading to increased cell proliferation similar to the
effect of C16 (Fig. 5C).
In line with the results from RT-qPCR analysis shown in
Figure 4B, western blot analysis indicated that p21 and p19
proteins were expressed at substantially higher levels in
D−/−ESCs than in ESCs, but their relative levels were not
affected by C16 (Fig. 6A). The relative levels of CDK2
(Fig. 6B) and cyclin E and A were not significantly altered in
either D−/−ESCs or ESCs by C16 treatment (data not
shown). However, CDC25A, a protein phosphatase that ac-
tivates CDKs and leads to G1/S cell cycle progression (34),
is upregulated in D−/−ESCs (Fig. 6B). This result could
contribute to the reduction of G1 phase cells by C16 in
D−/−ESCs.
The contributions of PKR and IFNβ to the cytotoxicity of
transfected RNA in D−/−ESCs
In routine cell culture, it is notable that there are more cells
undergoing spontaneous cell death in D−/−ESCs than in ESCs.
In particular, D−/−ESCs are more susceptible than ESCs to the
cytotoxicity of RNA transfection as shown in Fig. S1A. By
quantitatively analyzing the number of viable cells after
transfection with different concentrations of dsRNA, our re-
sults demonstrated that D−/−ESCs are more sensitive to the
cytotoxicity of dsGFP and dsLuc at all concentrations tested
(Fig. 7A). To determine the contribution of PKR to the cyto-
toxicity caused by RNA transfection, we pretreated cells with
C16 to block PKR activation prior to RNA transfection. As
shown in Figure 6B, the cytotoxicity caused by both dsGFP and
B2RNA can be partially reversed by C16 treatment.
We have previously reported that IFNα or IFNβ alone does
not have detectable effects on proliferation and viability of
ESCs (25, 26) or D−/−ESCs under normal conditions (data not
shown). To determine the contribution of IFNβ to the cyto-
toxicity in the cells transfected with RNA, we first
Figure 3. PKR activation in ESCs and D−/−ESCs. Cells were transfected
with dsGFP or B2 RNA for 6 h and 24 h. PKR activation was determined by
the levels of phosphorylated eIF2α (peIF2α, a substrate of PKR) and phos-
phorylated (activated) PKR (pPKR) with Western blot. β-Actin was used as a
reference for protein loading. The blots are representatives from experi-
ments that were repeated three times.
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preincubated ESCs and D−/−ESCs with IFNβ-neutralizing
antibodies, followed by cell transfection with dsRNA. The
rationale of this experiment is that the activity of IFNβ
secreted by the cells will be neutralized by the antibodies
before its autocrine signaling action. As shown in Figure 7C,
neither IFNβ-neutralizing antibodies nor control antibodies
affect the effect of dsRNA on ESC viability. However, IFNβ-
neutralizing antibodies, but not control antibodies, signifi-
cantly reduced the cytotoxicity of dsGFP and dsLuc on
D−/−ESCs (Fig. 7C). Similar results were observed when the
cells were transfected with polyIC or B2RNA (data not shown).
These results suggested that IFNβ contributes to the cyto-
toxicity only in D−/−ESCs in which it can be produced, but not
in ESCs that are deficient in expressing this cytokine.
Together, these data suggest that both PKR activation and
IFNβ production contribute to the cytotoxicity associated with
antiviral responses in D−/−ESCs.
Discussion
Using GFP expressed from its synthetic mRNA as an siRNA
target, we detected Dicer-dependent RNAi activity in ESCs, a
conclusion similar to the results reported in a study using GFP
expressed from a plasmid (23). However, the features of syn-
thetic RNA as viral RNA analogs allowed us to reveal strikingly
different antiviral responses between ESCs and D−/−ESCs.
Namely, Dicer deficiency leads to the acquisition of the ability
to express type I IFN and constitutive PKR activation in
D−/−ESCs. These two features potentially make D−/−ESCs
Figure 4. Analysis of cell proliferation and cell cycle regulator expression in ESCs and D−/−ESCs. A, cell proliferation analysis. Cells were seeded at
about 30% confluence in a 48-well plate. The cell numbers at the indicated time points were determined by cell viability assay. The cell number at day 1 for
both ESCs and D−/−ESCs is set as 1. B, RT-qPCR analysis of mRNA levels of cell cycle regulators. The basal mRNA level of each tested gene in ESCs is
designated as 1. The values are as mean ± SD of three independent experiments (B) or a representative experiment performed in biological triplicate that
was performed at least twice (A). p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05.* Compared groups are indicated by a horizontal bar.
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more susceptible to the cytotoxicity associated with antiviral
responses, either from viral RNA or from misprocessed
cellular RNA. These findings not only provide important in-
sights into the molecular basis underlying the phenotypes of
D−/−ESCs, but also reveal the biological function of Dicer in
the regulation of ESC immunological properties, pluripotency,
and proliferation.
Since the deficiency in expressing type I IFN is a common
feature of all types of pluripotent cells, it appears that this is an
intrinsic feature inherently related to the pluripotent state (3).
However, findings from this study further suggest that lack of
IFN expression in ESCs is not entirely restricted by pluripo-
tency, but it is also repressed by Dicer since D−/−ESCs have
retained ESC morphology and pluripotency marker expression
and in fact fail to exit the pluripotent state (14, 15). These
features presumably made D−/−ESCs a seemingly useful
model to study RNAi in mammalian cells in the pluripotent
state with an underdeveloped IFN antiviral system. However, it
is quite surprising to find that D−/−ESCs have gained the
ability to express type I IFN as we demonstrated in this study
and in a recent report in which increased activity against viral
infection was also noted in D−/−ESCs by other investigators
(16). This finding renders D−/−ESCs as an undesirable model
system to study RNAi antiviral activity in ESCs as we previ-
ously intended, and the constitutive activation of PKR in these
cells reveals a novel role of Dicer in controlling antiviral re-
sponses caused by dysregulated cellular RNA.
The constitutively activated PKR in D−/−ESCs may have
several biological implications. The PKR pathway is functional
in ESCs and is activated during mitosis by cellular dsRNA in a
highly regulated manner (35). We previously reported that
polyIC-activated PKR inhibits ESC proliferation, which can be
partly reversed by PKR knockdown with siRNA or by C16 PKR
inhibitor treatment (25). The effect of polyIC was replicated
with synthetic dsRNA and B2RNA in this study. In addition to
viral RNA, PKR can be activated by cellular RNA with certain
features of dsRNA, such as misprocessed RNA and transcripts
of transposable elements (TEs) (27–29, 36). Dicer is a key
component in the pathway for siRNA and miRNA biogenesis.
It also plays a critical role in preventing the “sterile inflam-
matory response” by silencing/processing endogenous RNA, in
particular TE transcripts that are especially abundant and
active in early embryos (37). In human cells, Dicer deficiency
leads to accumulation of Alu, increased antiviral response, and
accelerated apoptosis (27, 38, 39). Furthermore, PKR is acti-
vated by ectopically expressed Alu (35). B2RNA is the mouse
Figure 5. Effects of PKR inhibition on cell proliferation and cell cycle of
ESCs and D−/−ESCs. A, cells were seeded at about 30% confluence and
cultured in the absence (Con) or presence of PKR inhibitor C16 at the
indicated concentrations. The cell numbers were determined by cell
viability assay after 60 h incubation. The cell number in the control (Con)
was set as 100%. B, cells were treated under the conditions as described in A
for 48 h. Cell cycle was analyzed by flow cytometry. Insets show percentages
of cell populations in different phases. Arrows denote the changes of G1
phase cells in control and C16 (1 μM)-treated cells. The histograms are
representatives of flow profiles from experiments that were repeated three
times with similar results. C, cells were transfected with siRNA against PKR
(siPKR) or control siRNA (siCon). After 48 h incubation, the cell number was
determined by the method described in A. The number of cells without
transfection (Con) was set as 100%. PKR knockdown is assessed by Western
blot analysis. The blot inset shows two sets of independent samples. In bar
graphs, the values are as mean ± SD of a representative experiment per-
formed in biological triplicate that was performed at least twice (A) or the
mean ± SD of two combined independent experiments each performed in
biological triplicate (C). p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05.*
Compared groups are indicated by a horizontal bar.
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counterpart of Alu in humans (30). B2RNA, accumulated in
D−/−ESCs, could be one of many cellular RNAs accumulating
from Dicer deletion that contribute to the constitutive acti-
vation of PKR, leading to retarded cell cycle progression and
reduced cell viability in D−/−ESCs.
While the molecular mechanisms underlying how
D−/−ESCs have gained the ability to produce type I IFN
remain to be determined, we can logically assume that defi-
ciency in miRNA biogenesis would be a primary reason. In
particular, ESCs express a distinct set of miRNA, known as
ESC-specific miRNA (ESC-miRNA), that are critical for the
maintenance of the stem cell state (40). Although we have
rather limited knowledge about the miRNA that specifically
controls the innate immunity of ESCs, the most relevant
findings are that two members of the miR-290 cluster of ESC-
miRNA, miR-291b-5p, and miR-293, directly target the mRNA
of the RelA subunit of NFκB (41). This could contribute to the
inactive state of NFκB in ESCs since NFκB and IRFs are the key
transcription factors that control IFN expression (42). Indeed,
both NFκB and IRF3 can be activated in D−/−ESCs by polyIC,
but not in ESCs (16). Furthermore, mitochondrial antiviral-
signaling protein (MAVS), a signaling molecule that regu-
lates IFN expression, was identified as a target of miR-673 in
ESCs as reported in a recent study (16).
The rapid cell proliferation rate of ESCs is mainly driven by
high levels of cyclins A and E and the low levels of cell cycle
inhibitors (33). ESC-miR-291a-3p, ESC-miR-294, and ESC-
miR-295 directly target the mRNA of several molecules,
including p21, that inhibit cyclin/CDK activity (43), and this
logically explains the high levels of p21 and p19 in D−/−ESCs
and their slow rate of proliferation. It appears that PKR inhi-
bition by C16 in D−/−ESCs did not directly affect the
expression of p21, p19, or CDK2. However, this treatment
increased the expression level of CDC25A, a protein phos-
phatase that activates CDKs and leads to G1/S cell cycle
progression (34), which explains the increased cell prolifera-
tion of D−/−ESCs in the presence of C16. It should be pointed
out that a comprehensive assessment of PKR activity on the
functions of cell cycle regulators is very difficult due to their
large numbers and dynamic nature during the cell cycle pro-
gression. However, it is fairly certain that global translation
inhibition caused by PKR activation via phosphorylation of
eIF2α (6) could be a major mechanism of action of dsRNA and
B2RNA. Likewise, defining the precise contributions of IFN
responses to the phenotype of D−/−ESCs is also challenging
due to the fact that IFN can exert their effects in numerous
ways. Nonetheless, the results from the experiments with
IFNβ-neutralizing antibodies demonstrate that IFNβ (and
likely the other members of type I IFN) can potentiate the
cytotoxic effect of dsRNA, which could, at least partly, act
through the induction of de novo synthesis of PKR or other
ISGs.
The observation that D−/−ESCs can express type I IFN is
quite noticeable since normal ESCs do not produce these cy-
tokines. We are not aware of studies that specifically analyze
the effect of Dicer knockout on IFN response in differentiated
somatic cells. However, it has been reported that Dicer
knockdown with siRNA in endometrial cancer cells resulted in
an increased IFN response (44). It is also noted that both Dicer
knockout mouse embryonic fibroblasts and HEK293 cells
show reduced cell proliferation rate (45, 46). These findings
suggest that Dicer may share similar functions in ESCs and
differentiated cells. However, Dicer may play unique and
prominent roles in ESCs in which preventing antiviral re-
sponses and maintaining a rapid rate of cell proliferation are
fundamentally important for the normal growth and devel-
opment of an early embryo.
In summary, the data presented in this study further support
the hypothesis that antiviral responses could negatively impact
ESC function. We have identified Dicer as a repressor of both
the IFN system and the PKR pathway in ESCs at the plurip-
otent state. However, it should be pointed out that Dicer
regulates numerous cellular processes, directly or indirectly.
The specific mechanisms that lead to the acquisition of the
ability to express type I IFN and constitutive PKR activation in
D−/−ESCs remain to be determined.
Experimental procedures
Cells and cell culture
The immunological properties of mouse ESCs have been
investigated with two independent cell lines (D3 and DBA252)
in our previous studies (25, 26). Two pairs of wild-type mouse
ESCs (ESCs) and Dicer knockout ESCs (D−/−ESCs) were used
for most experiments to validate the results. They were
designated as ESC1 (D3 cell line, ATCC) and D−/−ESC1
(kindly provided by Dr Gregory Hannon) (14) and ESC2 and
D−/−ESC2 (kindly provided by Dr Phillip Sharp) (47). All ESCs
and D−/−ESCs were maintained in standard mouse ESC
Figure 6. Effects of PKR inhibition on the expression of cell cycle reg-
ulators. Cells were treated with different concentrations of C16 for 24 h and
analyzed by Western blot. β-Actin was used as a reference for protein
loading. The blots are representatives from experiments that were repeated
three times with similar results.
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medium that contains leukemia inhibitory factor (LIF) as
previously described (48). ESC-differentiated FBs (ESC-FBs,
differentiated from D3 ESCs) were cultured in ESC medium in
the absence of LIF as previously described (26, 32). All cells
were maintained at 37 C in a humidified incubator with 5%
CO2.
In vitro synthesis of RNA
Synthetic RNA were prepared by in vitro transcription ac-
cording to the methods that have been previously described
(18). Briefly, the DNA template for enhanced GFP mRNA
(GFP-mRNA) was generated from a pEGFP-N1 plasmid (BD
Biosciences) by PCR using Q5 High-Fidelity DNA polymerase
(New England BioLabs). The resulting dsDNA templates
contain the T7 u2.5 promoter for in vitro transcription
(49, 50), the 50-UTR region with a Kozak sequence (51), and
the open reading frame of GFP. To prepare functional GFP,
in vitro transcription from the DNA templates was carried out
in the presence of the cap analog m7GpppA (chemically
synthesized in our lab, unpublished) to generate 50-capped
GFP-mRNA transcripts. The purified RNA transcripts were
polyadenylated by E. coli Poly(A) polymerase (New England
Biolabs), resulting in functional mRNA, m7GpppA-GFP-polyA
(designated as GFP-mRNA).
To prepare double-stranded RNA (dsRNA), dsRNA con-
taining 650 nucleotides that nearly encompass the entire
length of GFP-mRNA and dsRNA containing 606 nucleotides
of Gausia luciferase mRNA (simplified as dsGFP and dsLuc,
respectively) were prepared by annealing the sense and anti-
sense RNA transcribed from separate templates of the same
sequences but with a T7 u2.5 promoter in opposite directions,
therefore having a perfect dsRNA structure. B2RNA is a 178
nucleotide RNA sequence corresponding to the B2 SINE that
is abundantly distributed in the mouse genome (30). It can fold
into a secondary structure with five hairpins, two loops, and
two single stranded regions (31). B2RNA was amplified by PCR
from both mouse genomic DNA and cDNA with the
primer pair 50-GGGCTGGTGAGATG-30 and 50-AAAG
ATTTATTTATTTATTATA-30. The DNA fragment was
cloned into a pB2 plasmid downstream of a T7 promoter by
our previously developed in vivo cloning method (52). Re-
striction digestion by BsaI at the end of the B2 sequence
resulted in a linearized DNA molecule, from which B2RNA
was synthesized by transcription with T7 RNA polymerase.
Cy3-labeled B2RNA (Cy3-B2) was prepared similarly but in
the presence of synthetic Cy3-AMP that acts as a transcription
initiator to yield fluorescent RNA (53)
Cell transfection and treatment
ESCs and D−/−ESCs were plated at 40 to 50% confluence
and were usually cultured for 24 h before the experiments.
Synthetic RNA were transfected into the cells with Endo-
fectin Max (Genecopoeia) at 300 ng/ml for GFP-mRNA,
Figure 7. Contributions of PKR activation and IFN response to the
cytotoxicity caused by RNA transfection in ESCs and D−/−ESCs. A, ef-
fects of dsGFP and dsLuc transfection on cell viability. B, inhibition of PKR
reduced cytotoxicity caused by dsGFP and B2 RNA transfection in D−/
−ESCs. Cells were pretreated with C16 (1 μM) for 30 min followed by
transfection with dsGFP or B2 RNA. The cell viability was determined after
24 h incubation. C, IFNβ-neutralizing antibodies reduced cytotoxicity caused
by dsGFP and dsLuc transfection in ESCs and D−/−ESCs. Cells were pre-
incubated with control isotype antibodies (Ab, Con) or IFNβ-neutralizing
antibodies (Ab, IFN) (2 μg/ml) for 30 min followed by transfection with
dsGFP or dsLuc. The cell viability was determined after 24 h incubation. The
cell number in the control (Con, cells without any treatment) was set as
100%. In all experiments, the values are as mean ± SD of a representative
experiments performed in biological triplicate that were performed at least
twice. p < 0.0001,****; p < 0.001,***; p < 0.01,**; p < 0.05*. Compared
groups are indicated by a horizontal bar.
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B2RNA, and polyIC (Sigma-Aldrich) and 200 ng/ml for
dsGFP and dsLuc, or at the concentrations specified in in-
dividual experiments. The imidazolo-oxindole PKR inhibitor
(C16, Sigma-Aldrich) was used to inhibit PKR activity as
previously described (25). To determine the effects of
secreted IFNβ on ESCs and D−/−ESCs transfected with
RNA, the cells were incubated with IFNβ-neutralizing anti-
bodies or isotype control antibodies (BioLegend) for 30 min
prior to RNA transfection. The cellular responses to type I
IFN were determined with mouse recombinant IFNα
(eBioscience). The treated cells were collected and used for
various analyses under conditions described in individual
experiments.
Preparation of conditioned medium (CM) and ELISA analysis
of IFNβ
CM preparation was carried out with protocols previously
described (54). Briefly, ESCs and D−/−ESCs were transfected
with dsGFP (200 ng/ml). After 4 h, the medium was removed,
and cells were thoroughly washed with PBS. The cells were
then cultured in DMEM that contains 15% FBS for an addi-
tional 24 h. CM prepared from cells without transfection with
dsGFP was used as control CM. The CM was collected and
centrifuged at 10,621g for 15 min, and the supernatants were
collected and used for the treatment of ESC-FBs. To analyze
IFNβ secreted to the culture medium, ESCs and D−/−ESCs
were transfected with dsGFP (1 μg/ml) in serum free medium
with 0.2% BSA. After 24 h, the culture medium was collected,
concentrated with a centrifugal concentrator (10 kd cutoff),
and analyzed for IFNβ protein using a quantitative mouse
ELISA kit (BioLegend) according to the manufacturer’s
instruction.
Microscopy and flow cytometry analysis of GFP expression
Cell morphology and viability were routinely monitored
with an Olympus CKx31 phase-contrast microscope dur-
ing the time course of treatment. Expression of GFP in
live cells was visualized using a Leica fluorescence
microscope (DFC3000G). The images were acquired with a
digital camera mounted on the microscope. The cell
population expressing GFP was quantitatively determined
by flow cytometry with an Accuri C6 flow cytometer (BD
Biosciences) (18). Cell gating was performed by selecting
the cell population from forward versus side scatter (FSC
versus SSC) dot plots to exclude debris. Histograms that
represent GFP expression levels were generated from
median fluorescence intensities of analyzed samples with
CFlow software (BD Biosciences) as previously described
(18).
Cell viability and cell cycle analysis
The viability of ESCs and D−/−ESCs was determined by cell
number and by cell morphology after toluidine blue (TB)
staining. The absorbance at 630 nm of TB-stained cells was
measured with a microtiter plate reader. The values, which
correlate with the number of viable cells, were used as an in-
direct measurement of cell proliferation or viability. Cell cycle
analysis was performed with an LSRFortessa flow cytometer
(BD Biosciences) after the cells were stained with 50 μg/ml
propidium iodide. The cell cycle profiles were generated using
FlowJo software.
siRNA transfection and PKR knockdown
siRNA targeting PKR and negative control siRNA (Santa
Cruz Biotechnology) were transfected to the cells with Endo-
fectin Max at a final concentration of 100 nM. The cells were
then analyzed for siRNA knockdown efficiency and the effect
on cell proliferation under the specified experimental
conditions.
Western blot analysis
Protein analysis by Western blot was performed according
to our published method (25). The antibodies against β-Actin,
STAT1, PKR, pPKR, p19, p21, CDC25A, and CDK2 were
purchased from Santa Cruz Biotechnology and peIF2α anti-
bodies were from Cell Signaling Technology.
Table 1
The primer sequences used for RT-qPCR

















Cyclin E1 CCTCCAAAGTTGCACCAGTTTGC GACACACTTCTCTATGTCGCACC
Cyclin A2 CAGTCACAGGACAGAGCTGG GGGCATGTTGTGGCGCTTTG
Cyclin B1 CGAGAACTGCTCTTGGAGACATTG CCTGACACAGATACTCTTCTGCAG
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Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNA was extracted using Tri-reagent (Sigma). cDNA
was prepared by MMLV reverse transcriptase (Promega). RT-
qPCR was performed using SYBR green ready mix on an
MX3000PTM RT-PCR system (Stratagene), as previously re-
ported (48). The mRNA level from RT-qPCR was calculated
using the comparative Ct method (55). β-Actin mRNA was
used to normalize relative levels of mRNA for tested genes.
The sequences of the primer sets are listed in Table 1.
Statistical analysis
Statistical analysis was performed with Microsoft Excel us-
ing a two-tailed and unpaired Student’s t-test. Data are pre-
sented as the mean ± SD under specified experimental
conditions. Statistical differences are indicated by p-values. p<
0.05* was considered statistically significant. p values up to
four significant digits are shown as specified in figure legends.
Data availability
All data described in this study are either presented in the
main article or in the supporting information.
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